Want to create an interactive transcript for this episode?
Podcast: Anesthesiology News Presents
Episode: WHO Addresses Cannabinoid Hyperemesis Syndrome
Description: The WHO has added cannabinoid hyperemesis syndrome (CHS) to its diagnostic manual, establishing a new dedicated ICD-10-CM (International Classification of Diseases, 10th Revision, Clinical Modification) diagnosis code for the health condition. The update, which took effect Oct. 1, 2025, has also been adopted by the CDC. The goal was to facilitate healthcare providers in the United States to not only deliver a more conclusive diagnosis but to track and more precisely study the syndrome. CHS is an increasingly recognized complication of chronic cannabis use, characterized by severe abdominal pain and recurrent episodes of...